Chemokine Receptors

[1]  J. Tregoning,et al.  Immune Responses and Disease Enhancement during Respiratory Syncytial Virus Infection , 2005, Clinical Microbiology Reviews.

[2]  Albert Zlotnik,et al.  Pharmacological Characterization of CXC Chemokine Receptor 3 Ligands and a Small Molecule Antagonist , 2005, Journal of Pharmacology and Experimental Therapeutics.

[3]  J. Wityak,et al.  Identification of chemokine receptor CCR4 antagonist. , 2005, Bioorganic & medicinal chemistry letters.

[4]  C. Brightling,et al.  The CXCL10/CXCR3 axis mediates human lung mast cell migration to asthmatic airway smooth muscle. , 2005, American journal of respiratory and critical care medicine.

[5]  M. Schwarz,et al.  Multi-faceted strategies to combat disease by interference with the chemokine system. , 2005, Trends in immunology.

[6]  M. Wymann,et al.  Phosphoinositide 3-kinase in disease: timing, location, and scaffolding. , 2005, Current opinion in cell biology.

[7]  D. d'Ambrosio.  Targeting chemoattractant receptors in allergic inflammation. , 2005, Current drug targets. Inflammation and allergy.

[8]  Antonio Alcami,et al.  The chemokine receptor D6 limits the inflammatory response in vivo , 2005, Nature Immunology.

[9]  G. Trainor,et al.  Discovery of CC chemokine receptor-3 (CCR3) antagonists with picomolar potency. , 2005, Journal of medicinal chemistry.

[10]  I. Tillie‐Leblond,et al.  Inflammatory events in severe acute asthma , 2005, Allergy.

[11]  Aaron S. Anderson,et al.  Racemic and chiral lactams as potent, selective and functionally active CCR4 antagonists. , 2004, Bioorganic & medicinal chemistry letters.

[12]  M. Mack,et al.  Interference with Heparin Binding and Oligomerization Creates a Novel Anti-Inflammatory Strategy Targeting the Chemokine System , 2004, The Journal of Immunology.

[13]  C. Ding,et al.  Bertilimumab Cambridge Antibody Technology Group. , 2004, Current opinion in investigational drugs.

[14]  S. Orkin,et al.  A Critical Role for Eosinophils in Allergic Airways Remodeling , 2004, Science.

[15]  S. Durham,et al.  CCR4 ligands are up-regulated in the airways of atopic asthmatics after segmental allergen challenge , 2004, European Respiratory Journal.

[16]  W. Busse,et al.  Enhanced generation of helper T type 1 and 2 chemokines in allergen-induced asthma. , 2004, American journal of respiratory and critical care medicine.

[17]  N. Lukacs,et al.  Respiratory syncytial virus-induced chemokine production: linking viral replication to chemokine production in vitro and in vivo. , 2004, The Journal of infectious diseases.

[18]  R. Offord,et al.  Inhibition of Airway Inflammation by Amino-Terminally Modified RANTES/CC Chemokine Ligand 5 Analogues Is Not Mediated through CCR3 , 2003, The Journal of Immunology.

[19]  M. Liu,et al.  Release of both CCR4-active and CXCR3-active chemokines during human allergic pulmonary late-phase reactions. , 2003, The Journal of allergy and clinical immunology.

[20]  S. Phipps,et al.  Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics. , 2003, The Journal of clinical investigation.

[21]  J. Boehm,et al.  p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases , 2003, Nature Reviews Drug Discovery.

[22]  P. Finan,et al.  Isoform-specific phosphoinositide 3-kinase inhibitors as therapeutic agents. , 2003, Current opinion in pharmacology.

[23]  A. Gruber,et al.  CXCR2 Regulates Respiratory Syncytial Virus-Induced Airway Hyperreactivity and Mucus Overproduction1 , 2003, The Journal of Immunology.

[24]  C. Martínez-A,et al.  Absence of CCR8 Does Not Impair the Response to Ovalbumin-Induced Allergic Airway Disease 1 , 2003, The Journal of Immunology.

[25]  W. Henderson,et al.  CCR8 Is Not Essential for the Development of Inflammation in a Mouse Model of Allergic Airway Disease , 2003, The Journal of Immunology.

[26]  J. Mudgett,et al.  Functional Expression and Characterization of Macaque C-C Chemokine Receptor 3 (CCR3) and Generation of Potent Antagonistic Anti-macaque CCR3 Monoclonal Antibodies* , 2002, The Journal of Biological Chemistry.

[27]  R. Förster,et al.  Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells. , 2002, Blood.

[28]  A. Roshak,et al.  Small-molecule inhibitors of NF-κB for the treatment of inflammatory joint disease , 2002 .

[29]  I. Pavord,et al.  Mast-cell infiltration of airway smooth muscle in asthma. , 2002, The New England journal of medicine.

[30]  Dominique Schols,et al.  AMD3100, a CxCR4 antagonist, attenuates allergic lung inflammation and airway hyperreactivity. , 2002, The American journal of pathology.

[31]  C. Hogaboam,et al.  CXCR2 Is Necessary for the Development and Persistence of Chronic Fungal Asthma in Mice1 , 2002, The Journal of Immunology.

[32]  Clare Lloyd,et al.  Chemokines in allergic lung inflammation , 2002, Immunology.

[33]  T. Huynh,et al.  RANTES Activates Jak2 and Jak3 to Regulate Engagement of Multiple Signaling Pathways in T Cells* , 2001, The Journal of Biological Chemistry.

[34]  Tong-Yuan Yang,et al.  Aberrant in Vivo T Helper Type 2 Cell Response and Impaired Eosinophil Recruitment in Cc Chemokine Receptor 8 Knockout Mice , 2001, The Journal of experimental medicine.

[35]  M. Thelen,et al.  Dancing to the tune of chemokines , 2001, Nature Immunology.

[36]  P. Finan,et al.  Phosphoinositide 3-kinase γ: a key modulator in inflammation and allergy , 2001 .

[37]  I. Homma,et al.  Intervention of Thymus and Activation-Regulated Chemokine Attenuates the Development of Allergic Airway Inflammation and Hyperresponsiveness in Mice1 , 2001, The Journal of Immunology.

[38]  K. Chung,et al.  Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsìveness, and the late asthmatic response , 2000, The Lancet.

[39]  J. Gutiérrez-Ramos,et al.  Non‐redundant functional groups of chemokines operate in a coordinate manner during the inflammatory response in the lung , 2000, Immunological reviews.

[40]  A. Alcamí,et al.  Viral mechanisms of immune evasion , 2000, Molecular Medicine Today.

[41]  M. Peck,et al.  A Small Molecule Antagonist of Chemokine Receptors CCR1 and CCR3 , 2000, The Journal of Biological Chemistry.

[42]  A. Peled,et al.  Critical Involvement of the Chemotactic Axis CXCR4/Stromal Cell-Derived Factor-1α in the Inflammatory Component of Allergic Airway Disease , 2000, The Journal of Immunology.

[43]  Yolande Chvatchko,et al.  A Key Role for Cc Chemokine Receptor 4 in Lipopolysaccharide-Induced Endotoxic Shock , 2000, The Journal of experimental medicine.

[44]  M. Loda,et al.  Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1 , 2000, Nature.

[45]  H. Brühl,et al.  Differential Activation of CC Chemokine Receptors by AOP-RANTES* , 2000, The Journal of Biological Chemistry.

[46]  P. Allavena,et al.  Chemokine receptors: interaction with HIV-1 and viral-encoded chemokines. , 2000, Pharmaceutica acta Helvetiae.

[47]  A. Zlotnik,et al.  Chemokines in allergy. , 1999, Current opinion in immunology.

[48]  C. Meisel,et al.  Crucial Role of the Interleukin 1 Receptor Family Member T1/St2 in T Helper Cell Type 2–Mediated Lung Mucosal Immune Responses , 1999, The Journal of experimental medicine.

[49]  P. Askenase,et al.  C-C chemokines in allergen-induced late-phase cutaneous responses in atopic subjects: association of eotaxin with early 6-hour eosinophils, and of eotaxin-2 and monocyte chemoattractant protein-4 with the later 24-hour tissue eosinophilia, and relationship to basophils and other C-C chemokines (mono , 1999, Journal of immunology.

[50]  G. Yu,et al.  Mouse monocyte-derived chemokine is involved in airway hyperreactivity and lung inflammation. , 1999, Journal of immunology.

[51]  S. Rankin,et al.  Mechanisms of Acute Eosinophil Mobilization from the Bone Marrow Stimulated by Interleukin 5: The Role of Specific Adhesion Molecules and Phosphatidylinositol 3-Kinase , 1998, The Journal of experimental medicine.

[52]  C. Martínez-A,et al.  The Coordinated Action of CC Chemokines in the Lung Orchestrates Allergic Inflammation and Airway Hyperresponsiveness , 1998, The Journal of experimental medicine.

[53]  C. Mackay,et al.  Flexible Programs of Chemokine Receptor Expression on Human Polarized T Helper 1 and 2 Lymphocytes , 1998, The Journal of experimental medicine.

[54]  F. Saulnier,et al.  Bronchial neutrophilia in patients with noninfectious status asthmaticus. , 1998, American journal of respiratory and critical care medicine.

[55]  A. Proudfoot,et al.  The CC chemokine antagonist Met‐RANTES inhibits eosinophil effector functions through the chemokine receptors CCR1 and CCR3 , 1997, European journal of immunology.

[56]  C. Boshoff,et al.  Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines. , 1997, Science.

[57]  T. Schwartz,et al.  Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist. , 1997, Science.

[58]  C. Mackay,et al.  Chemokine receptor usage by human eosinophils. The importance of CCR3 demonstrated using an antagonistic monoclonal antibody. , 1997, The Journal of clinical investigation.

[59]  D. Davies,et al.  The chemokines: their potential role in allergic inflammation , 1996, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[60]  C. Mackay,et al.  Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils , 1996, The Journal of experimental medicine.

[61]  J. Demartino,et al.  Cloning, expression, and characterization of the human eosinophil eotaxin receptor , 1996, The Journal of experimental medicine.

[62]  M. Montjovent,et al.  Extension of Recombinant Human RANTES by the Retention of the Initiating Methionine Produces a Potent Antagonist (*) , 1996, The Journal of Biological Chemistry.

[63]  P. Murphy,et al.  Human cytomegalovirus open reading frame US28 encodes a functional beta chemokine receptor. , 1994, The Journal of biological chemistry.

[64]  P. Barnes.  New drugs for asthma , 2004, Nature Reviews Drug Discovery.

[65]  S. Durham,et al.  Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. , 1992, The New England journal of medicine.

[66]  James J. Lee,et al.  Ablation of eosinophils leads to a reduction of allergen-induced pulmonary pathology. , 2003, American journal of physiology. Lung cellular and molecular physiology.